EP2249765
Dapsone to treat rosacea
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.2.2008EP published:
13.11.2019EP application number:
08726129.3
EPO information:
European Patent Register
Max expiry date:
26.2.2028
Title:
Dapsone to treat rosacea
Timeline
Today
27.2.2008EP application
13.11.2019EP Publication
Owner
Name:
ALLERGAN, INC.Address:
2525 Dupont Drive, 92612, Irvine, CA, US
Inventor
Name:
GARRETT, John StevenAddress:
Fort CollinsCO, US
Classification
Categories:
A61K 31/145, A61P 17/10, A61K 8/46, A61Q 19/00, A61K 9/00, A61K 9/06, A61K 47/32